{"id":17685,"date":"2026-03-03T00:32:35","date_gmt":"2026-03-02T23:32:35","guid":{"rendered":"https:\/\/valintermed.com\/?p=17685"},"modified":"2026-03-03T00:32:35","modified_gmt":"2026-03-02T23:32:35","slug":"antitela-k-grippu-kak-oni-rabotayut-i-pochemu-ih-nedostatochno","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/antibodies-to-the-flu-how-they-work-and-why-they-are-insufficient-2\/","title":{"rendered":"Antibodies to influenza: how they work and why they are not enough"},"content":{"rendered":"
<\/div>\n

Influenza is not just a \"cold with a fever.\" It is an acute viral respiratory disease caused by RNA viruses of the genus *Influenzavirus*, which can paralyze the operations of entire enterprises in just a few days, overload hospitals, and, in severe cases, lead to death. Unlike ARVI, influenza develops rapidly: within 1-2 days after infection, a person may feel as if they have been \"hit by a truck\" \u2014 joint pain, fever up to 40 \u00b0C, headache, weakness, cough, nasal congestion. And although most cases end with recovery within 7-10 days, influenza remains one of the main causes of seasonal hospitalizations and sudden death among the elderly and people with chronic diseases. It is particularly concerning that even after the infection, immunity to the virus is incomplete \u2014 and this is where antibodies come into play: powerful, but not omnipotent defenders of our body.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n